Search Results
An update on the use of FMT for the treatment of steroid- and ruxolitinib-resistant acute GvHD
Ruxolitinib: Treatment of Steroid-Refractory Acute GVHD
Pooled allogenic FMT for the treatment of steroid-refractory intestinal acute GvHD
Future perspectives in FMT for the treatment of GvHD
Feasibility of FMT to prevent acute GvHD after alloHSCT & restore gut microbiota diversity
Ruxolitinib Appears Effective as Treatment of Steroid-Refractory GVHD
Utilizing JAK Inhibition to Treat Acute GVHD
Clinical Perspective: Integrating Ruxolitinib into the Treatment of Acute GVHD
Recent advances in the management of acute GvHD
What's the latest in treatment of steroid-refractory acute GvHD at ASH 2021?
Unmet needs in SR-aGvHD and TR-aGvHD
Overcoming GVHD Is the Key to Better HCT Outcomes: Guidance on Managing Acute and Chronic Disease
